PharmGen Science, Inc.
Research PharmGen Science, Inc. (004720.KS) on Bullrun: market cap KRW 62.75B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker004720.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencyKRW
- Market capKRW 62.75B
- Financial periodQ2 2026
- RevenueKRW 47.72B
- Net income-KRW 13.58B
- Free cash flowKRW 4.69B
- Gross margin66.5%
Valuation Snapshot
latest market cap is KRW 62.75B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 62.75B | n/a | n/a | n/a |
Dividend history
About PharmGen Science, Inc.
PharmGen Science, Inc. engages in the research and development, production, and sale of pharmaceutical products in South Korea. It provides prescription drugs, OTC drugs, diagnostic test kits, health and general foods, and cosmetics, as well as shampoo, conditioner, and hair oil products under the neomcell brand name. The company was formerly known as Wooridul Pharmaceutical Limited and changed its name to PharmGen Science, Inc. PharmGen Science, Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is PharmGen Science, Inc.'s market cap?
PharmGen Science, Inc.'s market capitalization is KRW 62.75B.
What does PharmGen Science, Inc. do?
PharmGen Science, Inc. engages in the research and development, production, and sale of pharmaceutical products in South Korea. It provides prescription drugs, OTC drugs, diagnostic test kits, health and general foods, and cosmetics, as well as shampoo, conditioner, and hair oil products under the neomcell brand name. The company was formerly known as Wooridul Pharmaceutical Limited and changed its name to PharmGen Science, Inc. PharmGen Science, Inc. was founded in 1966 and is headquartered in Hwaseong-si, South Korea.